Ora Oxford University Research
metadata only
Envisioning the development of a CRISPR-Cas mediated base editing strategy for a patient with a novel pathogenic CRB1 single nucleotide variant
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Engineered CRISPR-Base Editors as a Permanent Treatment for Familial Dysautonomia#403767
- From CRISPR functional genomics to synthetic interventions: engineering antiviral strategies.#122905
- Emerging and Potential use of CRISPR in Human Liver Disease#345407
- CRISPR-SWITCH (silent mutations with intention to create heterozygotes): a strategy for monoallelic genome editing and generation of a Syt1-D365E mouse model of Baker-Gordon syndrome.#402717
- Optimized crispr/cas9 systems and methods for gene editing in stem cells — Editas Medicine, Inc. (US20230126434A1)#607213
Record · ID 193884
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive